Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. A modest advance in therapeutic cloning. This week a Korean team announced that they had used the same techniques used by an Oregon team just … Continue reading Stem cell stories that caught our eye: therapeutic cloning, growing nerves and reprogramming cells.

Guest blogger Sergio Pistoi served with me on the Public Education Committee of the International Society for Stem Cell Research and in 1998 was a fellow in a science journalist fellowship program I directed at Harvard Med School. He writes for many major publications and consults with scientist on communicating their work. In the latter … Continue reading Is the ability of European scientists to work with human embryonic stem cells being jeopardized by DIY (do it yourself) communication

In a move that takes stem cell-based therapies for spinal cord injury one step closer in the long march from the lab bench to routine clinic use, StemCells, Inc., today announce that they have completed enrollment in a clinical trial that aims to treat chronic spinal cord injury. This Phase I/II trial will evaluate the … Continue reading Dual Clinical Trial Announcements Offers New Hope for Treating Spinal Cord Injury

The parents of children with cerebral palsy (CP) rank high in number among the desperate calls that come to CIRM wanting to know about stem cell therapies offered on the internet. They don’t like to hear that we have very little information suggesting benefit from stem cells in these kids and that there is little … Continue reading A placebo-controlled trial in cerebral palsy might unlock some answers for parents

Entrepreneurs and researchers are finding new sources to cross the "valley of death" funding gap. Neil Littman is the Business Development Officer at CIRMIn February I gave a talk at the Phaciliate Conference in Washington D.C. entitled Bridging the Funding Gap: Non-Profit and Industry Collaborations, CIRM’s Perspective. Phacilitate is an annual conference focused on the … Continue reading Changing landscape of funding stem cell therapies: not just a venture capitalist’s game

Here are some stem cell stories that caught our eye this past week. Some are groundbreaking science, others are of personal interest to us, and still others are just fun. Attack on cancer stem cell advancing with a broad aim. Most of the advances in cancer in recent years require matching very specific therapies to … Continue reading Stem cell stories that caught our eye: cancer therapy with broad aim, lupus and politics again

Get in that wheel and exercise little guy; it's good for your brain.We have long known the brain is not static. Parts of it change and become stronger in response to being stimulated. This “plasticity” as it is called, is generally attributed to changes in the nerves themselves. But a CIRM-funded Stanford team now has … Continue reading Living proof exercising the brain helps it function, provides clues to improving stem cell therapy

New brochure that describes our stem cell bank initiative [download pdf]Geoff Lomax is CIRM's Senior Officer for Medical & Ethical Standards One thing patients and their families can do to advance the role of stem cells in curing disease is to donate a small skin or blood sample if asked. How can this help? Here … Continue reading Stem cell agency educating patients on how they can make a difference

Cynthia Schaffer supports CIRM’s Business Development and Industry Engagement and Commercialization activities. We always consider ourselves on the front wave of technology here in California. We have Silicon Valley and a huge biotechnology sector. We are also the state that voted to create CIRM, the largest funder of stem cell research outside of the National … Continue reading Start the conversation, ask your relatives about stem cell value